CRISPR and Stem Cells Help Identify New Chlamydia Drug Targets

News   Apr 26, 2017 | Original story from the Wellcome Trust

 
CRISPR and Stem Cells Help Identify New Chlamydia Drug Targets

A human macrophage interacting with a chlamydia cell. Credit: Sanger Institute, Genome Research Limited

 
 
 
 

RELATED ARTICLES

Biological Fingerprint of Tuberculosis Meningitis Discovered in Children

News

Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

READ MORE

Clear View on Stem Cell Development

News

Scientists from the Technical University of Munich and the Helmholtz Zentrum München have devised image correction software which can simplify the quantification of stem cells.

READ MORE

Lab Grown Human Colons Change Study of GI Disease

News

Researchers have grown human colon with human pluripotent stem cells, enabling further study of the GI tract and associated diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE